Suppr超能文献

母血循环中胎儿血细胞的分析:挑战、持续努力及潜在解决方案。

Analysis of fetal blood cells in the maternal circulation: challenges, ongoing efforts, and potential solutions.

作者信息

Guetta Esther, Simchen Michal J, Mammon-Daviko Keren, Gordon Daphna, Aviram-Goldring Ayala, Rauchbach Nurit, Barkai Gad

机构信息

Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel-Hashomer, Israel 52621.

出版信息

Stem Cells Dev. 2004 Feb;13(1):93-9. doi: 10.1089/154732804773099290.

Abstract

The invasive procedures amniocentesis and chorionic villus sampling (CVS) are routinely applied in pregnancies at risk for fetal abnormalities and the results obtained are the gold standard for prenatal diagnosis. Because these methods of fetal cell procurement involve a 0.5-2% risk for fetal loss, they are recommended mainly in cases at high risk for fetal genetic or cytogenetic abnormalities. The development of a reproducible, reliable, noninvasive method based on retrieval of rare fetal cells from the maternal circulation will render testing feasible for the general population. Despite intensive investigation, a satisfactory, clinically acceptable method has not yet emerged. Several cell types have been targeted to this end, mostly nucleated red blood cells (NRBC), CD34+ hematopoietic progenitors, and trophoblasts. Although these cell types have been unequivocally proven to be present in the maternal circulation, each bears a significant disadvantage, rendering their application in clinical testing currently impossible: NRBC cannot be expanded in culture, thereby ruling out metaphase chromosome analysis, an essential component of prenatal diagnosis. CD34+ cells do posses the potential for in vitro proliferation, however, they have been found to persist in the maternal circulation after delivery, thereby complicating diagnosis in consecutive pregnancies. Trophoblasts are not consistently detected in the maternal circulation. Moreover, due to the lack of a definitive fetal cell marker and a reliable sorting method, foolproof fetal cell identification of any of these cell types is not possible. This report outlines the obstacles that impede development of a method for noninvasive fetal cell sampling for prenatal genetic diagnosis, along with a description of our efforts to analyze simultaneously two fetal blood cell types, NRBC and CD34+ cells in maternal blood during pregnancy, and the problems encountered. This work and that of others lead us to suggest potential future directions to help develop this important technique.

摘要

羊膜穿刺术和绒毛取样(CVS)等侵入性操作通常应用于有胎儿异常风险的妊娠中,所获得的结果是产前诊断的金标准。由于这些获取胎儿细胞的方法存在0.5%-2%的胎儿丢失风险,因此主要推荐用于胎儿遗传或细胞遗传学异常风险较高的情况。基于从母体循环中获取罕见胎儿细胞而开发一种可重复、可靠的非侵入性方法,将使普通人群也能进行检测。尽管进行了深入研究,但尚未出现一种令人满意的、临床上可接受的方法。为此已针对几种细胞类型进行研究,主要是有核红细胞(NRBC)、CD34+造血祖细胞和滋养层细胞。尽管已明确证实这些细胞类型存在于母体循环中,但每种都有一个重大缺陷,使得它们目前无法应用于临床检测:NRBC无法在培养中扩增,从而排除了中期染色体分析,而中期染色体分析是产前诊断的一个重要组成部分。CD34+细胞确实具有体外增殖的潜力,然而,已发现它们在分娩后仍会持续存在于母体循环中,从而使连续妊娠的诊断变得复杂。滋养层细胞在母体循环中并非总能检测到。此外,由于缺乏明确的胎儿细胞标志物和可靠的分选方法,无法对这些细胞类型中的任何一种进行万无一失的胎儿细胞鉴定。本报告概述了阻碍开发用于产前基因诊断的非侵入性胎儿细胞取样方法的障碍,同时描述了我们在孕期母体血液中同时分析两种胎儿血细胞类型(NRBC和CD34+细胞)的努力以及所遇到的问题。这项工作以及其他研究使我们提出了潜在的未来方向,以帮助开发这项重要技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验